ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

ClinicalTrials.gov ID: NCT04143217

Public ClinicalTrials.gov record NCT04143217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Extension Study to Evaluate the Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With Attention-Deficit/Hyperactivity Disorder

Study identification

NCT ID
NCT04143217
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Supernus Pharmaceuticals, Inc.
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

  • SPN-812 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 22, 2020
Primary completion
Jul 25, 2022
Completion
Dec 13, 2022
Last update posted
Feb 12, 2024

2020 – 2022

United States locations

U.S. sites
38
U.S. states
13
U.S. cities
36
Facility City State ZIP Site status
South California Research LLC Beverly Hills California 90210
Collaborative Neuroscience Network Garden Grove California 92845
Pharmacology Research Institute Los Alamitos California 90720
Pharmacology Research Institute Newport Beach California 92660
Artemis Research Institue for Clinical Research Riverside California 92078
Artemis Institute for Clinical Research San Diego California 92103
Artemis Institute for Clinical Rearch San Marcos California 92078
Collaborative Neuroscience Network LLC Torrance California 90502
Gulfcoast Research Center Fort Myers Florida 33912
Research Centers of America Hollywood Florida 33024
Clinical Neuroscience Solutions, Inc Jacksonville Florida 32217
Meridien Research Lakeland Florida 33805
Florida Clinical Research Center, LLC Maitland Florida 32751
Medical Research Group of Central Florida Orange City Florida 32763
Clinical Neuroscience Solutions Inc. Orlando Florida 32801
CNS Healthcare Orlando Florida 32806
Meridien Research Tampa Florida 33634
Atlanta Center for Medical Research Atlanta Georgia 30331
iResearch Atlanta Decatur Georgia 30030
Psych Atlanta Marietta Georgia 30060
Psychiatric Associates Overland Park Kansas 66211
St. Charles Psychiatric Associates Midwest Research Center Saint Charles Missouri 63304
Alivation Research, LLC Lincoln Nebraska 68526
Altea Research Institute Las Vegas Nevada 10549
Center for Psychiatry and Behavioral Medicine, Inc. Las Vegas Nevada 89128
Hassman Research Institute Berlin New Jersey 08009
Center for Emotional Fitness Cherry Hill New Jersey 08002
Hassmann Research Institute Marlton New Jersey 08053
Princeton Medical Institute Princeton New Jersey 08540
Bioscience Research Mount Kisco New York 10549
The Medical Research Network LLC New York New York 10128r
Paradigm Research Professionals Oklahoma City Oklahoma 73188
Clinical Neuroscience Solutions Memphis Tennessee 38119
BioBehavioral Research of Austin P.C. Austin Texas 78759
FutureSearch Trials of Dallas, LLP Dallas Texas 75231
Houston Clinical Trials Houston Texas 77098
Family Psychiatry of the Woodlands The Woodlands Texas 77381
Northwest Clinical Trials Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04143217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2024 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04143217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →